Effect of a Cardiac Rehabilitation Program on Chronic Heart Failure Patients in Yaoundé, Cameroon

NCT04790214 | Unknown DMC

• 1 other identifier: CARECA-CHF
• Study Type: interventional
• Target: 30
• Locations: 1 country
• Sites: 1

Brief Summary

CARECA-CHF study is a non-randomized, prospective, single-arm study, enrolled ambulatory patients with stable chronic heart failure \[New York Heart Association (NYHA) class II/III\]. Patients will be followed-up during a period of 06-08 weeks. The aim of this study is to assess the effect of a cardiac rehabilitation program on patients with stable chronic heart failure in Yaoundé, Cameroon.

Conditions

Chronic Heart Failure (CHF)

Keywords

Cardiac rehabilitation; Chronic Heart failure; Physical function; Cameroon

Outcome Measures

Primary Outcomes (1)

• Change of VO2 max

  Variation of VO2 max at baseline and the end of the study

  8 weeks

Secondary Outcomes (10)

• Variation in 6-minute walk test (6MWT) distance

  8 weeks

• Variation of duration of exercise and maximum load

  8 weeks

• Variation in level of anxiety and depression;

  8 weeks

• Change in quality of life assessed by the Minnesota Living With Heart Failure Questionnaire (MLWHFQ)

  8 weeks

• Variation of time-domain heart rate variability (HRV) parameters

  8 weeks

Study Arms (1)

Stable CHF patients

EXPERIMENTAL

Stable CHF patients on stage II/III based on the New York Heart Failure classification

Other: CHF Patients

Interventions

CHF Patients OTHER

Cardiac rehabilitation program on CHF patients on 06-08 weeks. Program will include: physical aerobic re-training, therapeutic education on CHF, psychological follow-up, nutritional education

Stable CHF patients

Eligibility Criteria

• Age: 21 Years - 80 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Patients with stable chronic heart failure confirmed by a cardiac ultrasound and whose severity is rated stage II or III of NYHA followed at Yaoundé central hospital and Yaoundé general hospital;
• Stable under treatment;
• Whose cardiac ultrasound is less than six months old;
• Having given his free and informed consent.

You may not qualify if:

• Poor adherence to the cardiac rehabilitation program activities;
• Patients lost insight the program;
• Withdrawal of informed consent.

Sponsors & Collaborators

• Yaounde Central Hospital: lead

Study Sites (1)

Dr Chris Nadège Nganou-Gnindjio

Yaoundé, BP: 35307 Bastos, Cameroon

Location

Study Officials

• Chris Nadège N Nganou-Gnindjio, MD, MAS

  Yaounde Central Hospital

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: SUPPORTIVE CARE
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER GOV
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Dr, Principal investigator

Model Details: Patients with stable CHF in stage II or III of the New York Heart Association.

Study Record Dates

• First Submitted: February 25, 2021
• First Posted: March 10, 2021
• Study Start: March 1, 2021
• Primary Completion: June 1, 2021
• Study Completion: September 1, 2021
• Last Updated: March 10, 2021

Record last verified: 2021-03

Locations

CA (1)